![]()
MIRA INFORM REPORT
|
Report Date : |
14.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
DROGUERIA INTI S.A. |
|
|
|
|
Registered Office : |
Lucas Jaimes No. 1959, La Paz |
|
|
|
|
Country : |
Bolivia |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
14.11.1947 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Manufacture and commercialization of medicinal
products for human use |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Bolivia |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
DROGUERIA INTI S.A.
N.I.T.: 1020521023
INCORPORATED IN 1947. FOLLOWER
OF ACTIVITIES. BALANCE SHEET AS OF 31/12/2010: BALANCED FINANCIAL POSITION WITH
POSITIVE FINAL PROFIT. FIT FOR CURRENT CREDITS WITH THE APPROPRIATE GUARANTEES.
MEDICINAL PRODUCTS FOR
HUMAN USE
MANUFACTURE
COMMERCIALIZATION
Business type: Public Limited Company
Incorporation date: 1947
Registered: 14/11/1947
Duration: Unlimited
End of fiscal year: 31/03
Legal, Administrative and Sales Address: Lucas
Jaimes No. 1959, La Paz, Bolivia.
Phone.: (591-2) 222-0200
Fax.: (591-2) 222-1981
E-mail: droguería@inti.com.bo
Website: www.inti.com.bo
Laboratory: Carretera a Viacha Km.15, El Alto,
Bolivia.
President: OHNES TANZER FRIEDRICH
Vicepresident: ANKER ARTEAGA FERNANDO
Secretary: LEMA MARIO
Trustee: CASTELLANOS
ORTIZ HUGO
The first two mentioned ones,
as Managers, are in charge of the management and administration of the company,
with the use of the social signature.
At 31/12/2010, the share
capital of the company was established on $ Bolivianos 63.957.600,00.- which was
totally suscribed and paid-in. It is not known neither who contributes such
amount nor the percentages.
According to our database,
we can say that these activities were initiated in 1936 by the company
DROGUERIA HAMBURGO LTDA., which operated until 1947.
At that moment, the holder
was incorporated as the follower of the activities, being located at the
previous mentioned addresses. It has several distribution centers in different
points of the country.
The company’s representatives
were very reluctant to supply accounting
information, so, through indirect sources we could obtain some figures
from the Balance Sheet dated on 31/12/2010, which are expresed in pesos
bolivianos.
ASSETS:
Total current assets 181.730.436,97
Total non-current
assets
117.020.098,74
--------------------
TOTAL ASSETS 298.750.535,71
==============
LIABILITIES:
Total current
liabilities
93.351.143,12
Total non-current
liabilities
61.562.372,03
--------------------
Total Liabilities
154.913.515,15
Net Worth
143.837.020,56
---------------------
TOTAL LIABILITIES
298.750.535,71
==============
INCOME STATEMENT:
Total Incomes
204.990.006,29
FINAL PROFIT
25.572.656,38
==============
At that moment, the holder
had a balanced financial position, because there was a good relation between
its current assets and current liabilities, with large own resources to support
the operations into play.
PROPERTIES:
This company is owner of
all the occupied premises which have a good realization value as a whole.
No title deeds were shown
as to verify if its property is unencumbered.
VEHICLES:
30 vehicles about which no
more details are known.
MATRIPLAST S.A. (Bolivia)
LAPAPELERA S.A. (Bolivia)
Both companies are
suppliers of this company.
It fulfills its commitments
within normal terms.
Payments are made in 30/60
and 90 days.
Good concept.
The company is engaged in
the manufacture of medicinal products for human use and related ítems.
It has a large laboratory,
with a modern technology.
The following products are
the last ones added to its long list:
* Mentisan Plus (Children’s
flu remedy)
* Gelofusine (Plasma Volume
Expander)
* LKD Gingival (Mouthwash)
* Mentisan Plus (Children’s
remedy)
* LKD Gingival (Toothpaste)
* Carqueja médica
(Gastrointestinal Digestive)
* Lipofundin (Caloric and
acid provision)
It carries out imports from
India, Argentina, Holand, Germany and Chile among other countries.
It exports to Germany,
Paraguay, Peru and United States.
MAIN SUPPLIERS:
B.BRAUN MELSUNGEN GmbH
(Germany)
NUTRICIA B.V. (Holand)
MATRIPLAST S.A. (Bolivia)
LAPAPELERA S.A. (Bolivia)
* 672 EMPLOYEES
BANCO BISA Headquarters
BANCO DE CREDITO DE BOLIVIA Headquarters
BANCO NACIONAL DE BOLIVIA Headquarters
BANCO MERCANTIL SANTACUZ Branch: La Paz
BISA SEGUROS S.A.
It is commercially related
with local and foreign companies. Many of them give it their credit support,
not making up to now objections about its payment behaviour.
* FULFILLMENT: WITHOUT
OBJECTIONS UP TO NOW.
Bearing in mind all the exposed
information, we consider feasible the credit treatment with the holder with the
request of the appropriate guarantees in accordance to the amounts into play.
![]()
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.02 |
|
UK Pound |
1 |
Rs.77.13 |
|
Euro |
1 |
Rs.67.56 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.